When the pandemic hit the U.S. in March 2020, the volume of anticoagulants and antiplatelets fell 43.4 percent because of a decrease in heparin, according to the research, which used IQVIA National Sales Perspective data.
The researchers from Los Angeles-based University of Southern California and Baltimore-based Johns Hopkins University studied the supply and demand from January 2018 to February 2021. They found that during the pandemic, the volume of the blood thinners “grew significantly more” compared to historical orders.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
